People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their ...

The Food and Drug Administration approved a higher-dose version of a popular class of obesity drugs on Thursday, the latest ...

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

GLP-1 drugs can suppress thirst cues, leading to dehydration exacerbated by side effects like nausea and diarrhea. There's an ...

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

Experimenters hope to harness the powerful effects of medications such as Ozempic and Wegovy at doses smaller than those studied most.

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

March 20 () - Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis ...

GLP-1 receptor agonist use in adults with concurrent type 2 diabetes and obesity was associated with increased risk for ...